Fantastic news and a great start to 2024, the MELD-ATG study has successfully treated its 114th participant. The study is now closed to recruitment and will focus on the all important follow-up of those in the study.
Huge congratulations and well done to all the study teams.
Yeyldi village Gautz - Click to view on Ko-fi - Ko-fi ❤️ Where creators get support from fans through donations, memberships, shop sales and more! The original 'Buy Me a Coffee' Page. My amazing friend Thora ❤️ https://t.co/DPQmxZekgH
🔊Over 100 people are now part of the Ver-A-T1D #trial! We are getting closer to our goal of 138 people with #type1diabetes taking part.
We would like to thank everyone involved for their great efforts!
On this World Diabetes Day, let's envision a brighter future! Science & trials through INNODIA's accredited sites bring hope for innovative treatments. As we strive together, may these efforts pave the way for improved lives with diabetes. #WorldDiabetesDay#INNODIA#diabetes